Flagship Pioneering as of March 31, 2021
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 12 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 43.2 | $2.7B | 21M | 130.95 | |
| Sana Biotechnology (SANA) | 18.4 | $1.1B | 34M | 33.47 | |
| Rubius Therapeutics | 16.3 | $1.0B | 39M | 26.50 | |
| Seres Therapeutics | 4.8 | $302M | 15M | 20.59 | |
| Evelo Biosciences | 3.9 | $246M | 23M | 10.70 | |
| Sigilon Therapeutics | 3.7 | $232M | 10M | 22.35 | |
| Foghorn Therapeutics (FHTX) | 2.7 | $167M | 13M | 13.18 | |
| Kaleido Biosciences Ord (KLDO) | 2.5 | $159M | 20M | 8.10 | |
| Denali Therapeutics (DNLI) | 2.5 | $156M | 2.7M | 57.10 | |
| Axcella Health Inc equity | 1.0 | $60M | 13M | 4.76 | |
| Codiak Biosciences | 0.6 | $39M | 2.6M | 15.08 | |
| Syros Pharmaceuticals | 0.4 | $22M | 2.9M | 7.48 |
